Empagliflozin — Dosing in CKD & Dialysis

Empagliflozin (SGLT2 Inhibitor): renal dosing adjustments, dialyzability (Not studied: removal of empagliflozin by hemodialysis has not been studied (Jardiance label 10), and the label has no peritoneal dialysis statement; plasma protein binding 86.2% (label 12.3). No published study of its removal

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.